LB12. Safety and Efficacy of Fidaxomicin and Vancomycin in Pediatric Patients with Clostridium difficile Infection: Phase III, Multicenter, Investigator-blind, Randomized, Parallel Group (SUNSHINE) Study

BACKGROUND: Clostridium difficile infection (CDI), a common cause of antibiotic-associated diarrhea, leads to substantial healthcare burden. In children and young adults, the incidence of CDI is increasing. Fidaxomicin (FDX) is a narrow-spectrum macrocyclic antibiotic treatment for CDI in adults, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Joshua, Kalocsai, Krisztina, Fortuny, Claudia, Lazar, Stefan, Bosis, Samantha, Korczowski, Bartosz, Petit, Arnaud, Bradford, Daniel, Incera, Elodie, Melis, Joost, Van Maanen, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253862/
http://dx.doi.org/10.1093/ofid/ofy229.2186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253862/
http://dx.doi.org/10.1093/ofid/ofy229.2186

Ejemplares similares